Categories: aggregated

Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity

For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.

Jason

Share
Published by
Jason

Recent Posts

Award-winning Curio Wellness cannabis products come to Missouri

Curio Wellness is now available for the first time in stores across Missouri. Find the…

2 days ago

Star signs and cannabis strains: July 2024 horoscopes

As summer sun shines down, so do the stars. July holds many promising opportunities for…

2 days ago

$60,000,000 Raised to Legalize Weed in Florida vs. $10,000 Donated to Stop Marijuana Legalization

Florida's cannabis legalization amendment represents a pivotal moment in the state's political and social landscape.…

2 days ago

The One Man Fighting to Keep Weed Illegal in America – Meet Kevin Sabet and His Misinformation Campaign about the Cannabis Plant

In their latest crusade, SAM is raising alarms over the DEA's potential rescheduling of cannabis…

2 days ago

How to Build Fully Automated Cannabis Grow Box (Material Costs Included)

I’ve had an idea for a long time now to integrate a grow box that…

4 days ago